Order results by:
| Issue | Title | |
| Vol 15, No 4 (2019) | Atrial Septal Aneurysm in Adult Patients of Therapeutic Hospital | Abstract similar documents |
| O. V. Ryazantseva, N. I. Lenkova, O. D. Ostroumova, E. V. Shikh, S. M. Rykova | ||
| "... (CCTD) of other localization. Material and methods. Identification of ASA as well as other signs ..." | ||
| Vol 7, No 4 (2011) | ON THE 125TH ANNIVERSARY OF ACETYLSALICYLIC ACID | Abstract similar documents |
| I. N. Bokarev, L. V. Popova | ||
| "... An experience of acetylsalicylic acid (ASA) clinical use since its synthesis in 1887 ..." | ||
| Vol 8, No 4 (2012) | ACETYLSALICYLIC ACID: WHAT'S NEW IN THE OLD DRUG? | Abstract similar documents |
| I. V. Zhirov | ||
| "... The results of recent trials on acetylsalicylic acid (ASA) efficacy are presented. Data ..." | ||
| Vol 8, No 5 (2012) | ACETYLSALICYLIC ACID: DO WE KNOW EVERYTHING ABOUT IT AND ITS PROPER USE? | Abstract similar documents |
| S. A. Boldueva, I. A. Leonova | ||
| "... Use of acetylsalicylic acid (ASA) in cardiology practice is presented. ASA modes of action ..." | ||
| Vol 8, No 2 (2012) | EFFICACY AND SAFETY OF ACETYLSALICYLIC ACID IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES | Abstract similar documents |
| S. N. Tolpygina, S. Yu. Martsevich, E. N. Khoseva, N. V. Kiseleva | ||
| "... Acetylsalicylic acid (ASA) use in the primary and secondary prevention of cardiovascular diseases ..." | ||
| Vol 3, No 4 (2007) | RESISTANCE TO ACETYLSALICYLIC ACID AND PREVALENCE OF THROMBOSIS IN PATIENTS WITH STABLE ANGINA | Abstract similar documents |
| N. F. Putchinyan, N. V. Furman, P. Ya. Dovgalevskyi | ||
| "... sensitivity to acetylsalicylic acids (ASA) in patients with stable angina. Material and methods. 96 patients ..." | ||
| Vol 9, No 4 (2013) | ACETYLSALICYLIC ACID: CONTROVERSIAL AND OUTSTANDING ISSUES | Abstract similar documents |
| E. N. Dankovtseva | ||
| "... Review of current ideas about the role of acetylsalicylic acid (ASA) in the primary prevention ..." | ||
| Vol 12, No 3 (2016) | CLINICAL AND LABORATORY CHARACTERISTICS OF PATIENTS WITH ISCHEMIC HEART DISEASE RESISTANT TO ACETYLSALICYLIC ACID IN PERIOPERATIVE PERIOD OF CORONARY ARTERY BYPASS GRAFT: RESULTS OF AN OPEN PROSPECTIVE STUDY | Abstract PDF (Eng) similar documents |
| Yu. I. Grinshtein, A. A. Kosinova, I. Yu. Grinshtein, A. V. Kovalev, V. G. Sukhovol'skiy, A. A. Savchenko | ||
| "... that are sensitive or resistant to acetylsalicylic acid (ASA) before and after coronary artery bypass graft (CABG ..." | ||
| Vol 8, No 2 (2012) | ACETYLSALICYLIC ACID IN THE PREVENTION OF ATHEROTHROMBOTIC EVENTS | Abstract similar documents |
| A. V. Govorin, A. P. Filev | ||
| "... of acetylsalicylic acid (ASA) in primary and secondary prevention of atherothrombotic events. Studies on the safety ..." | ||
| Vol 5, No 6 (2009) | RISK OF REPEATED THROMBOTIC EVENTS IN PATIENTS SURVIVED ACUTE CORONARY SYNDROME AND HAVING LABORATORY PROVEN RESISTANCE TO ACETYLSALICYLIC ACID | Abstract similar documents |
| N. F. Puchinyan, N. V. Furman, A. R. Kiselev, Ya. P. Dovgalevsky | ||
| "... to acetylsalicylic acid (ASA) therapy. Material and methods. 200 patients with ACS (aged 56,6±9,2 y.o.) were ..." | ||
| Vol 12, No 5 (2016) | Features of the Hemostasis and Platelets Enzyme Activity in Patients with Different Sensitivity to Acetylsalicylic Acid by the Acute Coronary Syndrome | Abstract similar documents |
| I. Yu. Grinshtein, A. A. Savchenko, Yu. I. Grinshtein, M. M. Petrova | ||
| "... in acetylsalicylic acid (ASA) sensitive and resistant patients with acute coronary syndrome (ACS). Material ..." | ||
| Vol 6, No 6 (2010) | COMPARISON OF ANTIPLATELET EFFICACY OF ORIGINAL AND GENERIC ENTEROSOLUBLE ACETYLSALICYLIC ACID IN PATIENTS WITH HIGH CARDIOVASCULAR RISK. SIMPLE BLIND CROSSED RANDOMIZED CONTROLLED STUDY (IKAR) | Abstract similar documents |
| S. Yu. Martsevich, S. N. Tolpygina, E. S. Boychenko, R. E. Dubinskaya, Yu. V. Lukina, V. P. Voronina | ||
| "... acetylsalicylic acid (ASA) in patients with high cardiovascular risk. Material and мethods. Patients (n=30 ..." | ||
| Vol 4, No 2 (2008) | ANTIPLATELET THERAPY RESISTANCE IN PATIENTS WITH ACUTE CORONARY SYNDROME WITH ST-SEGMENT ELEVATION | Abstract similar documents |
| D. H. Ainetdinova, A. Е. Udovichenko, V. A. Sulimov | ||
| "... Aim. To evaluate the incidence of acetylsalicylic acid (ASA) and clopidogrel resistance ..." | ||
| Vol 17, No 4 (2021) | Monitoring of Aspirin Therapy in Patients with Cerebrovascular Pathology | Abstract similar documents |
| M. M. Tanashyan, A. A. Raskurazhev, A. A. Kornilova, A. A. Shabalina, D. A. Abaimov, A. V. Naminov | ||
| "... manifestations of CVD. All patients received acetylsalicylic acid (ASA) 75 mg daily. Along with a comprehensive ..." | ||
| Vol 5, No 4 (2009) | GASTROENTEROPATHIES ASSOCIATED WITH ACETYLSALICYLIC ACID: HOW TO IMPROVE SAFETY OF THERAPY | Abstract similar documents |
| A. L. Komarov | ||
| "... Lesion of gastrointestinal mucous coat is the main factor limited acetylsalicylic acid (ASA) use ..." | ||
| Vol 4, No 1 (2008) | COMPARISON OF ANTIPLATELET EFFECT AND SAFETY OF ORIGINAL DRUG «ASPIRIN CARDIO» AND GENERIC«ACECARDOL» IN PATIENTS WITH ARTERIAL HYPERTENSION 1-2 GRADE | Abstract similar documents |
| N. A. Belolipetskiy, S. N. Tolpygina, O. А. Litinskaya, V. G. Belolipetskaya, S. Yu. Martsevich | ||
| "... .o. were included in the study. They took investigated ASA medicines one after another during 4 weeks each ..." | ||
| Vol 18, No 1 (2022) | The Impact of Combination Therapy with Rivaroxaban and Acetylsalicylic Acid in Patients with Coronary Heart Disease on the Achievement of the Target for Reducing Mortality from Cardiovascular Diseases of the Federal Project "Fight against Cardiovascular Diseases" | Abstract similar documents |
| M. V. Zhuravleva, A. V. Panov, A. R. Kuksenok | ||
| "... Aim. To assess the outcomes of combination therapy with rivaroxaban and acetylsalicylic acid (ASA ..." | ||
| Vol 8, No 2 (2012) | RESIDUAL PLATELET REACTIVITY DURING THERAPY WITH INHIBITORS OF CYCLOOXIGENASE OR ADENOSINE DIPHOSPHATE RECEPTORS | Abstract similar documents |
| A. A. Lomonosova, N. A. Mazur, E. A. Zolozova, E. V. Sayutina, V. V. Chigineva, N. V. Shestakova | ||
| "... Aim. To compare effects of acetylsalicylic acid (ASA) and two clopidogrel drugs on residual ..." | ||
| Vol 16, No 3 (2020) | A Prospective, Initiative, Single-Center Open Post-Registration Comparative Study of Laboratory Efficacy of Various Forms of Acetylsalicylic Acid in a Cardioprotective Dose with Different Composition of Excipients: Results of the SFAIROS Study | Abstract similar documents |
| N. V. Lomakin, L. I. Buryachkovskaya, D. A. Zolin, V. I. Kazey | ||
| "... and pharmacokinetic parameters of branded generic preparations of acetylsalicylic acid (ASA) in buffered form ..." | ||
| Vol 13, No 1 (2017) | ANTIPLATELET THERAPY OF ATRIAL FIBRILLATION: FOCUS ON THE ELDERLY | Abstract similar documents |
| E. А. Ushkalova, S. K. Zyryanov, E. V. Dumchenko | ||
| "... that risk associated with acetylsalicylic acid (ASA) use in patients ≥75 years can overweigh its potential ..." | ||
| Vol 12, No 4 (2016) | High residual platelet reactivity during dual antiplatelet therapy, found by optical aggregometry and the rate of atherothrombotic complications after coronary artery stenting in patients with ischemic heart disease in clinical practice | Abstract similar documents |
| N. F. Puchinyan, N. V. Furman, P. V. Dolotovskaya, L. L. Malinova | ||
| "... antiplatelet therapy (DAT) with acetylsalicylic acid (ASA) and clopidogrel by optical aggregometry in patients ..." | ||
| Vol 14, No 3 (2018) | APPROACHES TO THE CHOICE OF ANTICOAGULANT THERAPY IN THE TREATMENT OF PATIENTS WITH COMBINATION OF ATRIAL FIBRILLATION WITH CORONARY HEART DISEASE OR PERIPHERAL ATHEROSCLEROSIS: POTENTIAL OF APIXABAN | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov, I. Yu. Orlova, E. A. Smolyarchuk, J. S. Pavlova | ||
| "... as a drug of choice from the P2Y12 inhibitor group, the use of low doses of acetylsalicylic acid (ASA ..." | ||
| Vol 20, No 2 (2024) | Characteristics of the Russian population of patients with coronary artery disease or peripheral artery disease in the XATOA registry | Abstract similar documents |
| V. S. Arakelyan, A. D. Erlikh, N. Sh. Amirov, E. Dubar, K. Vogtlaender, S. Debus | ||
| "... inhibition therapy with rivaroxaban 2,5 mg twice a day and low-dose acetylsalicylic acid (ASA) daily were ..." | ||
| Vol 18, No 3 (2022) | Study the Association of Nucleotide Polymorphisms in Platelet Receptor and Cytochrome P450 Genes with the Development of Resistance to Antiplatelet Drugs in Patients with Coronary Artery Disease | Abstract similar documents |
| K. S. Semashchenko, T. S. Mongush, A. A. Kosinova, T. N. Subbotina, Y. I. Grinshtein | ||
| "... 140 patients in the acetylsalicylic acid (ASA) treatment group and 103 patients in the dual ..." | ||
| Vol 5, No 3 (2009) | ANTIPLATELET DRUGS RESISTANCE IN PATIENTS WITH ISCHEMIC HEART DISEASE AND OBLITERATIVE ATHEROSCLEROSIS OF LOWER LIMB ARTERIES ASSOCIATED WITH DIABETES MELLITUS TYPE 2 | Abstract similar documents |
| E. V. Gorjacheva, A. E. Udovichenko, V. A. Sulimov, N. V. Lavrishcheva, M. A. Surikova, T. N. Gracheva | ||
| "... Aim. To study a rate of resistance to acetylsalicylic acid (ASA) and clopidogrel and clinical ..." | ||
| Vol 7, No 5 (2011) | THE ADHERENCE TO RECOMMENDED THERAPY IN PATIENTS AFTER ACUTE CORONARY SYNDROME, AND RISK OF CARDIOVASCULAR COMPLICATIONS WITHIN A YEAR AFTER HOSPITAL ADMISSION | Abstract similar documents |
| N. F. Puchin'yan, Ya. P. Dovgalevskiy, P. V. Dolotovskaya, N. V. Furman | ||
| "... . Complex therapy (acetylsalicylic acid (ASA), beta-blockers (BB), ACE inhibitors, statins) was prescribed ..." | ||
| Vol 9, No 1 (2013) | POSSIBILITIES OF CLINICAL LABORATORY EVALUATION OF ANTIPLATELET THERAPY EFFECTIVENESS IN PATIENTS WITH ISCHEMIC HEART DISEASE | Abstract similar documents |
| O. V. Sirotkina, A. B. Laskovets, A. S. Lipunova, L. B. Gaykovaya, S. A. Boldueva, T. V. Vavilova | ||
| "... and induced flow cytofluorometry during antiplatelet therapy with clopidogrel and acetylsalicylic acid (ASA ..." | ||
| Vol 17, No 1 (2021) | Aspirin Resistance as a Result of Impaired Interaction of Platelets and Neutrophils in Patients with Coronary Heart Disease | Abstract similar documents |
| M. D. Goncharov, A. A. Savchenko, Yu. I. Grinshtein, I. I. Gvozdev, A. A. Kosinova, T. S. Mongush | ||
| "... bypass grafting (CABG), depending on sensitivity to acetylsalicylic acid (ASA). Material and methods ..." | ||
| Vol 15, No 3 (2019) | Study of the Association of V640L (rs6133) Polymorphism in the Platelet P-selectin Gene with Acetylsalicylic Acid Resistance in Patients after Coronary Bypass Surgery | Abstract similar documents |
| A. A. Kosinova, T. S. Mongush, M. D. Goncharov, T. N. Subbotina, K. S. Semashchenko, G. Y. Kochmareva, Yu. I. Grinshtein | ||
| "... with acetylsalicylic acid (ASA) resistance in patients with coronary heart disease after coronary bypass surgery (CABG ..." | ||
| Vol 20, No 6 (2024) | Platelet reactivity clinical and biochemical markers when taking acetylsalicylic acid as part of dual antiplatelet therapy in the myocardial infarction subacute period | Abstract similar documents |
| T. P. Pronko, V. A. Snezhitskiy, A. V. Kapytski | ||
| "... of myocardial infarction (MI) during the administration of acetylsalicylic acid (ASA) as part of dual ..." | ||
| Vol 14, No 5 (2018) | Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part I: Study Rationale, Design and Assessment of Effectiveness | Abstract similar documents |
| N. Yu. Mironov, V. V. Vlodzyanovskiy, Yu. A. Yuricheva, S. F. Sokolov, S. P. Golitsyn, L. V. Rosenstraukh, E. I. Chazov | ||
| "... in 27 of 30 patients (90%) in DCC group and in 28 of 30 patients (93.3%) in PCV group. 95% confidence ..." | ||
| Vol 7, No 5 (2011) | PRE-HOSPITAL THROMBOLYSIS IN KRASNOYARSK: RESULTS OF A RETROSPECTIVE COMPARATIVE STUDY | Abstract similar documents |
| S. A. Skripkin, A. V. Lolenko, V. V. Radionov, M. V. Man'ko, A. E. Bulak | ||
| "... , respectively. The effective pre-hospital thrombolysis was registered in 93.3% of patients as demonstrated ..." | ||
| Vol 19, No 3 (2023) | Association of polymorphic variants of CYP2C19, P2RY12, ITGB3, ITGA2 and eNOS3 genes with high residual platelet reactivity while taking clopidogrel and acetylsalicylic acid at different terms of myocardial infarction | Abstract similar documents |
| T. P. Pronko, V. A. Snezhitskiy, T. L. Stepuro, A. V. Kapytski | ||
| "... and acetylsalicylic acid (ASA) at different terms of myocardial infarction (MI). Material and methods. The study ..." | ||
| Vol 11, No 4 (2015) | THE ATTITUDE TOWARDS TREATMENT OF CARDIOVASCULAR DISEASES: A SURVEY OF PATIENTS OF STATE OUTPATIENT CLINICS AND PRIVATE MEDICAL CENTERS | Abstract similar documents |
| O. N. Semenova, E. A. Naumova, Yu. G. Shvarts | ||
| "... (57.7%) and 3 private outpatient clinics (42.2%) was conducted in Saratov. Results. 33.3 ..." | ||
| Vol 4, No 5 (2008) | COMPARISON OF EFFICACY AND SAFETY OF RAMIPRIL, MOLSIDOMINE AND THEIR COMBINATION IN PATIENTS WITH CHRONIC HEART FAILURE, WHICH COMPLICATED ISCHEMIC HEART DISEASE | Abstract similar documents |
| I. I. Sinitsina, V. A. Orlov, G. J. Zaharova | ||
| "... status and decrease of class NYHA was found in 38,5% of patients in ramipril group; in 33,3% of patients ..." | ||
| Vol 16, No 3 (2020) | Efficacy of Trimetazidine and Sulodexide in Patients with Microvascular Angina | Abstract similar documents |
| S. A. Boldueva, I. A. Leonova, O. V. Zakharova | ||
| "... 86.2±29.7 to 129.5±41.0 ml/100g/min, p<0.05 for anterior interventricular artery; from 93.3±30 ..." | ||
| Vol 18, No 2 (2022) | Changes in Long-term Mortality in Patients with Myocardial Infarction History According to the LIS Luberetskiy registry | Abstract PDF (Eng) similar documents |
| S. Y. Martsevich, N. P. Zolotareva, A. V. Zagrebelnyy, M. L. Ginzburg, O. M. Drapkina | ||
| "... .0%), beta-blockers (93.3% vs 81.0%). Less commonly, diuretics are prescribed at discharge from the hospital ..." | ||
| Vol 18, No 5 (2022) | Clinical and Anamnestic Characteristics, Cardiovascular Pharmacotherapy and Long-term Outcomes in Multimorbid Patients after COVID-19 | Abstract similar documents |
| A. A. Smirnov, M. M. Loukianov, S. Yu. Martsevich, A. A. Pulin, N. P. Kutishenko, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, M. M. Kudryavtseva, O. V. Lerman, A. N. Makoveeva, E. Yu. Okshina, A. A. Maltseva, E. N. Belova, V. G. Klyashtorniy, E. V. Kudryashov, O. E. Karpov, O. M. Drapkina | ||
| "... .3-93.3%), CHD (90.4-91.4%), and minority – CHF (42.7-46.0%) and AF (42.9-43.4%). The combination of 3-4 ..." | ||
| Vol 17, No 1 (2021) | Multivariable Analysis of Primary Care Physician Adherence to Guideline-recommended Pharmacotherapy of Stable Coronary Artery Disease | Abstract similar documents |
| S. K. Zyryanov, S. B. Fitilev, A. V. Vozzhaev, I. I. Shkrebniova | ||
| "... (66,4 vs. 53,6%; p=0,004), arterial hypertension (93,3 vs. 79,7%; p<0,001) and dyslipidemia (21,4 vs ..." | ||
| Vol 20, No 4 (2024) | Nephroprotective and anticoagulant therapy in patients with atrial fibrillation and chronic kidney disease: real-world data | Abstract similar documents |
| A. I. Listratov, I. I. Ivanov, N. K. Ziskina, V. V. Efimenko, A. V. Zhavoronkova, E. S. Milyakova, A. A. Kudrjavtseva, D. A. Napalkov, A. A. Sokolova | ||
| "... сердечной недостаточностью со сниженной фракцией выброса (ХСНнФВ) — в 68,4% случаев. 196 (93,3%) пациентам с ..." | ||
| Vol 18, No 5 (2022) | Assessment of Drug Related Problems and Pharmacist Interventions in Inpatients with Cardiovascular Disease | Abstract PDF (Eng) similar documents |
| S. M. Biradar, B. Kohima, V. Nayak, S. Nandikol, V. Warad, S. M. Byakod, B. S. Hunasagi, S. R. Awasthi | ||
| "... discontinuation, 24 (33.3%) addition of a new drug, 4 (5.55%) change of dosage form, and 14 (19.4%) decrease ..." | ||
| Vol 13, No 1 (2017) | QUALITY OF LIFE, CLINICAL AND BIOCHEMICAL PARAMETERS IN HYPERTENSIVE PATIENTS WITH COMORBID CONDITIONS | Abstract similar documents |
| E. B. Akhmedova, B. U. Mardanov, K. K. Badeynikova, M. N. Mamedov | ||
| "... and COPD was more common in women than in men (66.7% vs 33.3%), and a body mass index >30 kg/m2 ..." | ||
| Vol 7, No 5 (2011) | A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ANTIANGINAL DRUGS OF DIFFERENT GROUPS — NITROVASODILATATOR (ISOSORBIDE-5-MONONITRATE SUSTAINED RELEASE) AND BETA-BLOCKER WITH VASODILATING ACTION (NEBIVOLOL) — IN PATIENTS WITH STABLE ANGINA | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, V. A. Egorov, A. V. Zagrebel'nyy, A. A. Serazhim, Yu. V. Lukina, N. A. Dmitrieva | ||
| "... -mononitrate (454.3±37.1 vs 310.6±13.3 s; p <0.001) and nebivolol (428.6±33.3 vs 310.6±13.3 s; p<0.01). In one ..." | ||
| Vol 9, No 1 (2013) | ASTHENIC DISORDERS IN ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION: MANAGEMENT POTENTIAL OF MELDONIUM | Abstract similar documents |
| M. E. Statsenko, S. V. Nedogoda, S. V. Turkina, I. A. Tyshchenko, L. V. Poletaeva, V. V. Tsoma, A. A. Ledyaeva, E. V. Chumachok | ||
| "... .7% (p<0.05), with reduced activity — on 33.3%, reduced motivation — on 25%. In group2 a number ..." | ||
| Vol 10, No 6 (2014) | DYNAMICS OF STRUCTURAL AND FUNCTIONAL STATUS OF MYOCARDIUM DUE TO COMBINATION THERAPY WITH AMLODIPINE AND BISOPROLOL IN PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
| I. L. Zapesochnaya, A. G. Avtandilov | ||
| "... .9%. A share of patients with normal LV geometry increased from 23.5 to 33.3%; while share of patients ..." | ||
| Vol 8, No 2 (2012) | PRELIMINARY RESULTS OF COMPARATIVE PHARMACOECONOMIC PROSPECTIVE STUDY OF DIFFERENT THERAPIES OF ARTERIAL HYPERTENSION | Abstract similar documents |
| E. I. Tarlovskaya, N. S. Maksimchuk, S. V. Malchikova, M. V. Avksentieva | ||
| "... % of patients achieved target BP levels for 24 weeks, while in L/A group — 33.3% of patients, and 16 ..." | ||
| Vol 17, No 5 (2021) | Efficiency of the Left Atrial Appendage Thrombus Dissolution in Patients with Persistent Nonvalvular Atrial Fibrillation with Warfarin or Direct Oral Anticoagulants Therapy | Abstract PDF (Eng) similar documents |
| E. S. Mazur, V. V. Mazur, N. D. Bazhenov, Yu. A. Orlov | ||
| "... 5 mg 2 times/day. Repeated transesophageal echocardiographic examination was performed on average 33.3 ..." | ||
| Vol 6, No 3 (2010) | ASSOCIATION OF CLINICAL AND GENETIC FACTORS WITH LEFT VENTRICLE HYPERTROPHY IN ARTERIAL HYPERTENSION | Abstract PDF (Eng) similar documents |
| T. Yu. Kuznetsova, D. V. Gavrilov, L. M. Samohodskaya, D. V. Rebrikov, S. A. Morozova, P. I. Makarevich, A. V. Kolotvin, A. B. Balatsky, A. Yu. Postnov, S. A. Boitsov | ||
| "... ,005) or diabetes (OR 3,33, р<0,0001) presence. At genetic factors evaluation decrease of LVH risk was revealed ..." | ||
| Vol 2, No 1 (2006) | EFFECT OF ANTIHYPERTENSIVE THERAPY WITH RILMENIDINE ON COGNITIVE FUNCTION IN ELDERLY HYPERTENSIVE PATIENTS | Abstract similar documents |
| S. V. Nedogoda, U. A. Brel, T. A. Tchalyaby, E. S. Kesareva, V. A. Tcoma | ||
| "... by 71.4%, 50% and 33.3% (p<0.05). Positive dynamics in characteristics of memory: number of words ..." | ||
| Vol 14, No 3 (2018) | ROLE OF SYNTAX SCORE SCALE IN THE STRATIFICATION OF THE NOSOCOMIAL RISK OF CARDIOVASCULAR COMPLICATIONS AND LETHALITY IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION | Abstract similar documents |
| D. B. Nemik, G. V. Matyushin, S. A. Ustyugov | ||
| "... (38.5% vs 20.6%, p<0.001), fewer patients to whom the FIS was applied (33.3% vs 45.7%; p=0 ..." | ||
| Vol 17, No 1 (2021) | Lipid Clinic is an Efficacious Model of Preventive Medicine | Abstract PDF (Eng) similar documents |
| A. V. Blokhina, A. I. Ershova, A. N. Meshkov, A. S. Limonova, V. I. Mikhailina, O. M. Drapkina | ||
| "... risk (68.2% vs. 35.4%). Revisiting patients (25.4%) reached LDL-c targets more often (33.3% of very ..." | ||
| Vol 15, No 3 (2019) | Vascular Remodeling Markers in Patients with Essential Arterial Hypertension Depending on Presence of Type 2 Diabetes Mellitus | Abstract similar documents |
| Yu. A. Danilogorskaya, E. A. Zheleznykh, E. A. Privalova, Yu. N. Belenkov, A. A. Shchendrigina, M. V. Kozhevnikova, G. A. Shakaryants, V. Y. Zektser, A. S. Lishuta, I. S. Ilgisonis | ||
| "... .00) after the tests with reactive hyperemia (29 [24; 33.3] vs 40.0 [35.0;43.3] cap/mm2; p=0.00) and venous ..." | ||
| Vol 19, No 6 (2023) | Acute kidney injury as a risk factor for atrial fibrillation after coronary artery bypass grafting — effects of sodium-glucose cotransporter-2 inhibitors | Abstract similar documents |
| L. V. Kremneva, L. A. Arutyunyan, L. I. Gapon, S. N. Suplotov, S. V. Shalaev | ||
| "... ,1 mmol/l — without pAF, p=0,025) one day after the intervention; postoperative AKI was revealed in 33,3 ..." | ||
| Vol 18, No 1 (2022) | Noncompact Myocardium with Dilated Phenotype: Manifestations, Treatment and Outcomes in Comparison with Other Forms of Dilated Cardiomyopathy Syndrome | Abstract PDF (Eng) similar documents |
| O. V. Blagova, E. V. Pavlenko, N. V. Varionchik, V. P. Sedov, N. V. Gagarina, E. A. Mershina, M. E. Polyak, E. V. Zaklyazminskaya, A. V. Nedostup | ||
| "... was 12.2% and 33.3%, respectively, and was significantly higher than in asymptomatic, ischemic ..." | ||
| Vol 20, No 1 (2024) | Clinical factors associated with the no/slow-reflow phenomenon in patients with acute coronary syndrome | Abstract similar documents |
| E. V. Konstantinova, Yu. S. Ilin, A. A. Velikotskiy, N. A. Rakhimi, A. A. Bogdanova, A. V. Ploshchenkov | ||
| "... проксимальный уровень поражения инфаркт-связанной артерии [ОШ=3,33; 95% ДИ 1,67-6,57; p<0,001]. Частота ..." | ||
| Vol 17, No 6 (2021) | Patients with a Combination of Atrial Fibrillation and Chronic Heart Failure in Clinical Practice: Comorbidities, Drug Treatment and Outcomes | Abstract PDF (Eng) similar documents |
| M. M. Loukianov, S. Yu. Martsevich, Yu. V. Mareev, S. S. Yakushin, E. Yu. Andreenko, A. N. Vorobiev, K. G. Pereverzeva, A. V. Zagrebelny, E. Yu. Okshina, V. V. Yakusevich, Vl. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. N. Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, E. N. Belova, V. G. Klyashtorny, E. V. Kudryashov, A. N. Makoveeva, Yu. E. Tatsiy, S. A. Boytsov, O. M. Drapkina | ||
| "... prescription of antiplatelet agents instead of anticoagulants was 52.5% and 33.3% (p<0.001) in the combination ..." | ||
| 1 - 57 of 57 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
